These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18481386)

  • 1. In vivo tracking of dendritic cells in patients with multiple myeloma.
    Prince HM; Wall DM; Ritchie D; Honemann D; Harrrison S; Quach H; Thompson M; Hicks R; Lau E; Davison J; Loudovaris M; Moloney J; Loveland B; Bartholeyns J; Katsifis A; Mileshkin L
    J Immunother; 2008; 31(2):166-79. PubMed ID: 18481386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
    Verdijk P; Aarntzen EH; Lesterhuis WJ; Boullart AC; Kok E; van Rossum MM; Strijk S; Eijckeler F; Bonenkamp JJ; Jacobs JF; Blokx W; Vankrieken JH; Joosten I; Boerman OC; Oyen WJ; Adema G; Punt CJ; Figdor CG; de Vries IJ
    Clin Cancer Res; 2009 Apr; 15(7):2531-40. PubMed ID: 19318472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells.
    Aarntzen EH; Srinivas M; Bonetto F; Cruz LJ; Verdijk P; Schreibelt G; van de Rakt M; Lesterhuis WJ; van Riel M; Punt CJ; Adema GJ; Heerschap A; Figdor CG; Oyen WJ; de Vries IJ
    Clin Cancer Res; 2013 Mar; 19(6):1525-33. PubMed ID: 23382117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration of human dendritic cells after injection in patients with metastatic malignancies.
    Morse MA; Coleman RE; Akabani G; Niehaus N; Coleman D; Lyerly HK
    Cancer Res; 1999 Jan; 59(1):56-8. PubMed ID: 9892184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface Mucin-1 does not play a role in dendritic cell migration.
    Cloosen S; Caberg JH; Huls MB; Vanderlocht J; Senden-Gijsbers BL; Roncarati P; Hubert P; Delvenne P; Germeraad WT; Bos GM
    Mol Immunol; 2009 Feb; 46(4):738-42. PubMed ID: 18952292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients.
    Ruiz A; Nomdedeu M; Ortega M; Lejeune M; Setoain J; Climent N; Fumero E; Plana M; León A; Alós L; Piera C; Lomeña F; Gatell JM; Gallart T; García F
    Immunotherapy; 2009 May; 1(3):347-54. PubMed ID: 20635955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.
    Kondo H; Hazama S; Kawaoka T; Yoshino S; Yoshida S; Tokuno K; Takashima M; Ueno T; Hinoda Y; Oka M
    Anticancer Res; 2008; 28(1B):379-87. PubMed ID: 18383873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A; Van de Velde AL; Nijs G; Braeckman T; Stein B; De Vries JM; Berneman ZN; Van Tendeloo VF
    Cytotherapy; 2009; 11(5):653-68. PubMed ID: 19530029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease.
    Sakuraba A; Sato T; Kamada N; Kitazume M; Sugita A; Hibi T
    Gastroenterology; 2009 Nov; 137(5):1736-45. PubMed ID: 19632232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
    Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
    Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.
    de Vries IJ; Lesterhuis WJ; Barentsz JO; Verdijk P; van Krieken JH; Boerman OC; Oyen WJ; Bonenkamp JJ; Boezeman JB; Adema GJ; Bulte JW; Scheenen TW; Punt CJ; Heerschap A; Figdor CG
    Nat Biotechnol; 2005 Nov; 23(11):1407-13. PubMed ID: 16258544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of radiolabelled human dendritic cells injected by various routes.
    Quillien V; Moisan A; Carsin A; Lesimple T; Lefeuvre C; Adamski H; Bertho N; Devillers A; Leberre C; Toujas L
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):731-41. PubMed ID: 15924229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired lung dendritic cell migration and T cell stimulation induced by immunostimulatory oligonucleotides contribute to reduced allergic airway inflammation.
    Constabel H; Stankov MV; Hartwig C; Tschernig T; Behrens GM
    J Immunol; 2009 Sep; 183(5):3443-53. PubMed ID: 19667097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine.
    Gustafsson K; Ingelsten M; Bergqvist L; Nyström J; Andersson B; Karlsson-Parra A
    Cancer Res; 2008 Jul; 68(14):5965-71. PubMed ID: 18632652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
    Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
    J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of monocyte-derived dendritic cells under the influence of platelets.
    Nguyen XD; Müller-Berghaus J; Kälsch T; Schadendorf D; Borggrefe M; Klüter H
    Cytotherapy; 2008; 10(7):720-9. PubMed ID: 18985478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma.
    Yang DH; Park JS; Jin CJ; Kang HK; Nam JH; Rhee JH; Kim YK; Chung SY; Choi SJ; Kim HJ; Chung IJ; Lee JJ
    Leuk Res; 2009 May; 33(5):665-70. PubMed ID: 18922577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response.
    Chen W; Zhang Z; Shi M; Chen L; Fu J; Shi F; Zhang B; Zhang H; Jin L; Wang FS
    Clin Immunol; 2008 Nov; 129(2):295-303. PubMed ID: 18774748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.